Display options
Cite
Diesel A, Moriello K. Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs. Vet Sci. 2015;2(1):13-22doi: 10.3390/vetsci2010013.
Diesel, A., & Moriello, K. (2015). Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs. Veterinary sciences, 2(1), 13-22. https://doi.org/10.3390/vetsci2010013
Diesel, Alison, and Moriello, Karen. "Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs." Veterinary sciences vol. 2,1 (2015): 13-22. doi: https://doi.org/10.3390/vetsci2010013
Diesel A, Moriello K. Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs. Vet Sci. 2015 Feb 05;2(1):13-22. doi: 10.3390/vetsci2010013. PMID: 29061926; PMCID: PMC5644608.
Copy Download .nbib Format: NLM
Share it on

Vet Sci. 2015 Feb 05;2(1):13-22. doi: 10.3390/vetsci2010013.

Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs.

Veterinary sciences

Alison Diesel, Karen Moriello

Affiliations

  1. Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA. [email protected].
  2. Department of Medical Sciences, School of Veterinary Medicine, 2015 Linden Drive West, University of Wisconsin, Madison, WI 53706, USA. [email protected].

PMID: 29061926 PMCID: PMC5644608 DOI: 10.3390/vetsci2010013

Abstract

Gingival overgrowth is an uncommon adverse effect of cyclosporine administration in veterinary species. In people, gingival overgrowth is a common complication of cyclosporine administration for immunosuppression, generally following transplant procedures. Azithromycin has been used successfully for managing gingival overgrowth in human transplant patients when cyclosporine administration cannot be reduced or discontinued. This case series describes six dogs being administered cyclosporine for various dermatologic diseases that developed gingival overgrowth. The dogs were prescribed systemic azithromycin, with or without concurrent dose reduction of cyclosporine. Oral administration of 6.6-10.8 mg/kg of azithromycin once daily for 4-14 weeks was effective for complete clinical resolution of gingival overgrowth. In most cases, gingival overgrowth did not recur even with continued cyclosporine administration long-term. Adverse events of long-term azithromycin administration did not occur in any of the dogs. This series highlights a potentially beneficial medical treatment option for gingival overgrowth even when cyclosporine dose reduction is not possible or elected, without the need for surgical resection of proliferative gingival tissue.

Keywords: azithromycin; cyclosporine; dog; gingival overgrowth

References

  1. Vet Dermatol. 2013 Jun;24(3):337-45, e74-5 - PubMed
  2. J Dent Res. 2008 Nov;87(11):1075-9 - PubMed
  3. Ann Pharmacother. 2000 Apr;34(4):495-513 - PubMed
  4. Antimicrob Agents Chemother. 1990 Jun;34(6):1056-60 - PubMed
  5. J Vet Dent. 2005 Sep;22(3):160-9 - PubMed
  6. J Periodontal Res. 2012 Apr;47(2):137-48 - PubMed
  7. Pharmacotherapy. 2001 Nov;21(11):1436-43 - PubMed
  8. Br Med J. 1980 Feb 16;280(6212):444-5 - PubMed
  9. Vet Surg. 2008 Apr;37(3):247-53 - PubMed
  10. Surg Forum. 1979;30:287-9 - PubMed
  11. Vet Dermatol. 2005 Apr;16(2):81-6 - PubMed
  12. BMC Oral Health. 2009 Dec 08;9:33 - PubMed
  13. Vet Dermatol. 2003 Feb;14(1):11-22 - PubMed
  14. Transplant Proc. 2004 Nov;36(9):2699-702 - PubMed
  15. J Oral Pathol Med. 1989 Apr;18(4):240-5 - PubMed
  16. Vet Rec. 2003 Jun 14;152(24):739-48 - PubMed
  17. J Periodontol. 1992 Jun;63(6):548-53 - PubMed
  18. Nephrol Dial Transplant. 1993;8(11):1254-8 - PubMed

Publication Types